logo
Man lives for 100 days with artificial titanium heart in successful new trial

Man lives for 100 days with artificial titanium heart in successful new trial

Yahoo12-03-2025

An Australian man lived for 100 days with an artificial titanium heart while he awaited a donor transplant, the longest period to date of someone with the technology.
The patient, a man in his 40s who declined to be identified, received the implant during surgery at St. Vincent's Hospital Sydney last November.
In February, he became the first person worldwide to leave hospital with the device, which kept him alive until a heart donor became available earlier this month.
According to a statement issued Wednesday by St Vincent's Hospital, Monash University and BiVACOR, the US-Australian company behind the device, the man, who had severe heart failure, was 'recovering well.'
The ability of the device to sustain him for so long is being celebrated as a sign the artificial heart could potentially offer a long-term option for people suffering heart failure. The device is still being trialed and has not yet been approved for general use.
BiVACOR's founder, Australian bioengineer Daniel Timms, who invented the device following his father's death from heart disease, said it was 'exhilarating to see decades of work come to fruition.'
'The entire BiVACOR team is deeply grateful to the patient and his family for placing their trust in our Total Artificial Heart,' he said in the statement. 'Their bravery will pave the way for countless more patients to receive this lifesaving technology.'
The BiVACOR Total Artificial Heart (TAH) has a single moving part, a levitated rotor that's held in place by magnets. As the name suggests, it's constructed from titanium and there are no valves or mechanical bearings that may be susceptible to wear.
It pumps blood to the body and the lungs, replacing both ventricles of a failing heart.
Cardiovascular diseases are the leading cause of death globally killing around 18 million people each year, according to the World Health Organization.
The long-term ambition is to use the device to save more people who languish on waiting lists for suitable donors. According to the US Health Department, about 3,500 people received heart transplants in 2024. Around 4,400 joined the waiting list the same year.
Professor Chris Hayward, from the Victor Chang Cardiac Research Institute, said the BiVACOR heart ushered in 'a whole new ball game for heart transplants.'
'Within the next decade we will see the artificial heart becoming the alternative for patients who are unable to wait for a donor heart or when a donor heart is simply not available,' said Hayward, who is overseeing the Australian patient's recovery and was involved in preparing the device for clinical trials.
The device has already been tested in the Food and Drug Administration's Early Feasibility Study in the United States, which saw five patients successfully implanted with the device.
The first was last July, when a 58-year-old man suffering end-stage heart failure received the implant during surgery at Texas Medical Center. It kept him alive for eight days until a donor was available.
Four other patients followed in the study, which examined the safety and performance of the device, while they waited for a donor transplant. It's hoped the trial will expand to 15 patients.
The Australian implant was the first in a series planned by Monash University's Artificial Heart Frontiers Program, a 50 million Australian dollar ($31 million) program to develop and commercialize three devices to treat heart failure.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Scientists make disturbing discovery in riverbed that could endanger millions: 'An emerging public health concern'
Scientists make disturbing discovery in riverbed that could endanger millions: 'An emerging public health concern'

Yahoo

time15 hours ago

  • Yahoo

Scientists make disturbing discovery in riverbed that could endanger millions: 'An emerging public health concern'

A new study has discovered evidence that the presence of microplastics in river water could influence microbial communities, leading to more pathogens and antimicrobial resistance genes. The research team collected water samples from the Oder River, which flows over 522 miles through Czechia, Germany, and Poland, putting them in sanitized containers and adding pre-drained sediment and microplastic particles. Compared to a control group, which did not contain microplastics, the test samples showed a higher abundance of pathogenic bacteria such as Aeromonas salmonicida, Vibrio spp., Escherichia coli, and Salmonella. The microplastic-contaminated samples also showed higher levels of antibiotic resistance genes, per the study published in Scientific Reports. "The presence of microplastics in [a] water environment and their bioavailability may contribute to, or alter the pattern of, the spreading of pathogens and antimicrobial resistance genes," the researchers stated, adding that this could be due to microbial competition and their use of microplastics to create biofilms, which makes these particles an environmentally favorable niche for some bacteria species. "This represents an emerging public health concern, particularly in the context of the One Health framework, which emphasizes the interconnectedness of human, animal, and environmental health," researchers said. Antimicrobial resistance genes are problematic because they help bacteria resist the drugs meant to treat them. Antimicrobial resistance is one of the top global health threats, according to the World Health Organization, which says it makes infections harder to treat and other medical procedures and treatments, such as surgery and chemotherapy, much riskier. Meanwhile, this is not the first time scientists have sounded the alarm about microplastics, which are small plastic particles that break off of larger plastics as they degrade. These plastics are everywhere, including in water, soil, air, clothing, seafood, and salt. For instance, one study found microplastics in nearly every protein source tested, including chicken, tofu, and beef. While researchers and experts still don't understand the health impacts of microplastics, they've been linked to health problems such as cancer, dementia, and impaired blood flow in the brain. These tiny plastic particles could also be harming some of the world's most important archaeological sites. Researchers in England called attention to this issue following the discovery of microplastics in the soil at two historic sites. While it's difficult to remove microplastics from the environment, it's not impossible. For instance, one group of scientists has discovered a way to rid water of microplastics by using egg whites. How often do you worry about the quality of your drinking water? Never Sometimes Often Always Click your choice to see results and speak your mind. Plus, some cities and countries are tackling plastic pollution, which is the source of microplastics. For one, England and France banned plastic cutlery for most fast food and takeout meals, while Los Angeles has banned Styrofoam takeout containers. You can cut down on your own plastic use at home by investing in reusable items like metal razors and non-plastic sandwich bags. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.

There's an Invisible Line That Animals Don't Cross. Here's Why.
There's an Invisible Line That Animals Don't Cross. Here's Why.

Yahoo

time15 hours ago

  • Yahoo

There's an Invisible Line That Animals Don't Cross. Here's Why.

The animal kingdoms of Asia and Australia are worlds apart, thanks to an invisible line that runs right between the two neighboring continents. Most wildlife never cross this imaginary boundary, not even birds. And so it has been for tens of millions of years, shaping animal evolution in different ways on each side. It all started about 30 million years ago, when the Australian tectonic plate bashed up against the Eurasian tectonic plate and created an archipelago, rerouting ocean currents and creating new regional climates. On one side of the map, in Indonesia and Malaysia, monkeys, apes, elephants, tigers, and rhinos evolved; while on the other side, in New Guinea and Australia, marsupials, monotremes, rodents, and cockatoos flourish. Very few species are abundant on both sides. The curious faunal divide is named Wallace's Line – after the naturalist Alfred Russel Wallace, who first noticed the stark difference in animal life (mostly mammals) while exploring the region in the mid-19th century. "We may consider it established that the Strait of Lombok [between Bali and Lombok] only 15 miles wide [24 kilometers] marks the limit and abruptly separates two of the great zoological regions of the globe," Wallace wrote. The naturalist later went on to independently develop a theory of evolution around the same time as Charles Darwin. The line he drew on a map more than a century ago is still considered a hypothetical evolutionary barrier, although debates continue as to its exact location and mechanisms. Generally speaking, Wallace's line separates a shelf of the Asian continent from a shelf of the Australian tectonic plate. It is a geological line, but it is also a climatic and biological one. Deep ocean channels like the Lombok Strait separate each shelf, which makes it difficult for animals to cross. Even when sea levels in the distant past were much lower than today, this chasm would have still existed. While Wallace's invisible line is most obvious when comparing mammals in Asia and Australia, it also exists for birds, reptiles, and other animals. Even creatures with wings don't typically make the trip across Wallace's line, and in the ocean, some types of fish and microbes show genetic differences on one side of the border compared to the other, indicating very little mixing between populations. Scientists have yet to figure out what invisible barriers are holding these species back. Habitat and climate, however, are probably factors accentuating the evolutionary divide. In 2023, an analysis of more than 20,000 vertebrate species found that Southeast Asian lineages evolved in a relatively tropical ancient environment that allowed them to spread out toward New Guinea on humid island "stepping stones". Wildlife on the Australian continental shelf, meanwhile, evolved in distinctly drier conditions, which dictated a different evolutionary path. This meant that Australian wildlife was at a disadvantage in the tropical islands nearer the equator. The more researchers study the Wallace line, however, the less clear it becomes about where the line should be drawn and how 'porous' the barrier might be – at least to some animals that can swim, float, or fly, like bats, beetles, monitor lizards, or macaques. Wallace's divide isn't an absolute border, but more of a gradient, scientists say. Even still, the blurry line helps us make sense of animal evolution for thousands of species. "Darwin's and Wallace's mental and actual maps were the table on which the evolutionary scheme was played out, comparable in importance to the geological time scale," argued science historian Jane Camerini in 1993 for the History of Science Society. What started as a single, roughly placed line, drawn more than a century ago, has now helped shape a bigger and more complicated picture of the natural world and its mysteries. Dehorning Rhinos Cuts Poaching by 78% – Saving Thousands of Animals' Lives Worms Use Their Bodies to Build Towers as a Wild Survival Strategy Elusive LSD Fungus Finally Discovered on Flower

Controversial 'alcohol alternative' coming to Woolworths this month: 'Impacts can vary'
Controversial 'alcohol alternative' coming to Woolworths this month: 'Impacts can vary'

Yahoo

timea day ago

  • Yahoo

Controversial 'alcohol alternative' coming to Woolworths this month: 'Impacts can vary'

A plant-based product promising relaxation, mood boosts, and even a safer alternative to alcohol is set to hit Woolworths shelves this month. A bitter-tasting drink made from the root of a Pacific Island plant, kava has long been used in traditional ceremonies across Polynesia. Now, it's being marketed as a wellness beverage in supermarkets across Australia. But not everyone is convinced. While the plant is often marketed as natural and non-intoxicating, the science behind kava's safety and efficacy is still emerging, particularly when it comes to modern, concentrated formulations, Dr Blair Aitken from Swinburne's Centre for Mental Health and Brain Science, told Yahoo News. Some hail its calming effects and link the substance to lower anxiety, while others warn that these commercialised forms come with poorly understood health risks and little regulation. "Kava contains active compounds called kavalactones, which can have a calming effect by influencing brain chemicals like gamma-aminobutyric acid (GABA) and dopamine," Dr Aitken explained. "It may reduce anxiety and promote relaxation without the intoxicating effects of alcohol, but its impact can vary widely depending on the formulation and dosage. "Kavalactones increase levels of GABA, a neurotransmitter that helps calm the brain and nervous system. They also enhance dopamine levels, which may improve overall mood and create a mild sense of well-being, and they slow down brain signals by blocking sodium and calcium channels, reducing overactivity in the nervous system." Woolworths is the latest major retailer to introduce kava-based products, joining Coles, which already offers a small range, including powders and capsules. The move is part of a broader trend following the federal government's 2021 import pilot program, which eased access to kava across most of the country. Commercial availability has since expanded, with products now found in chemists, health food stores, and increasingly on supermarket shelves. Unlike alcohol, Dr Aitken said, kava doesn't typically impair motor skills or reaction time when used in traditional or therapeutic amounts. "Its effects are more subtle and stabilising rather than intoxicating," he said. However there are still concerns, particularly when it comes to modern extracts and non-traditional preparations, he added. "There is no well-established toxic dose for kava," Dr Aitken said. "Most capsule formulations range from 50 to 100 mg of kavalactones, with a recommended maximum daily dose of 250 mg." "When prepared traditionally and used within recommended amounts, kava is considered safe by both the World Health Organisation and the Australian government. The substance shows few serious side effects when used short-term at recommended doses,' he said. "However, higher risks may occur with modern extracts, combined use with alcohol or medications, high doses, or use by individuals with underlying liver issues." Research into kava's use for treating anxiety has yielded mixed results. "While earlier trials showed promising results in generalised anxiety disorder, a more recent study by the same research group did not replicate those findings," Aitken said. "Kava appears more effective for situational or mild anxiety, rather than as a first-line treatment for diagnosed, clinically relevant anxiety." 🍎 Woolworths customers spark debate over brazen fruit act 💰 Woolworths responds to glaring pricing issue 👩 Aussie mum's sad supermarket confession: 'Do anything for my children' In Australia, kava is regulated as a food when imported for personal use or through approved programs. The Northern Territory bans personal importation and restricts use under separate legislation due to concerns about misuse and harm. Other states and territories allow limited personal use under federal guidelines. Internationally, the substance has a range of legal classifications — it's listed as a psychoactive substance in New Zealand, for example. The way kava is prepared also plays a key role in its safety. Traditional water-based methods extract kavalactones while leaving behind many of the potentially harmful compounds. In contrast, modern commercial products sometimes use alcohol or acetone as solvents, which can extract flavokavains—compounds that may negatively affect the liver and nervous system. Some also include stems or leaves, which have different and more toxic chemical profiles than the root. Coles offers several kava products, though not all have clear labelling around kavalactone content. For example, FijiKava Noble Root Powder contains an estimated 70–150 mg per 2.5g serving, but the exact amount is not specified. The TakiMai 50mL kava shot also lacks precise dosing information. By contrast, Bioglan Kava capsules sold at Chemist Warehouse offer standardised dosing, with 60 mg per capsule and a recommended daily intake of 60–120 mg — well within safe limits. "Transparent labelling is essential," Dr Aitken said. "Consumers should monitor their intake carefully and stay within the recommended daily limit." Dr Aitken is also a member of the International Council on Alcohol, Drugs and Traffic Safety (ICADTS) Special Interest Group for 'Driver State Monitoring Systems,' and noted that while kava is not typically associated with impairment, more research is needed around its effects on alertness and driving, especially at higher doses or in combination with other substances. With Woolworths set to join the expanding commercial kava market, health professionals are calling for increased transparency, clearer consumer education and regulatory oversight. "Just because it's natural doesn't mean it's risk-free," he said. Love Australia's weird and wonderful environment? 🐊🦘😳 Get our new newsletter showcasing the week's best stories.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store